Cara L. McDermott

885 total citations
51 papers, 586 citations indexed

About

Cara L. McDermott is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Oncology. According to data from OpenAlex, Cara L. McDermott has authored 51 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 15 papers in Economics and Econometrics and 14 papers in Oncology. Recurrent topics in Cara L. McDermott's work include Palliative Care and End-of-Life Issues (14 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Economic and Financial Impacts of Cancer (7 papers). Cara L. McDermott is often cited by papers focused on Palliative Care and End-of-Life Issues (14 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Economic and Financial Impacts of Cancer (7 papers). Cara L. McDermott collaborates with scholars based in United States, South Africa and Australia. Cara L. McDermott's co-authors include Scott D. Ramsey, David K. Blough, Sean D. Sullivan, Todd H. Wagner, Heather T. Gold, Ties Hoomans, Jeannine S. McCune, J. Randall Curtis, David A. Gruenewald and Josh J. Carlson and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Cara L. McDermott

47 papers receiving 576 citations

Peers

Countries citing papers authored by Cara L. McDermott

Since Specialization

Citations

This map shows the geographic impact of Cara L. McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cara L. McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cara L. McDermott more than expected).

Fields of papers citing papers by Cara L. McDermott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cara L. McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cara L. McDermott. The network helps show where Cara L. McDermott may publish in the future.

Co-authorship network of co-authors of Cara L. McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of Cara L. McDermott. A scholar is included among the top collaborators of Cara L. McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cara L. McDermott. Cara L. McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Criteria for Enrollment of Patients With COPD in Palliative Care Trials: A Systematic Review 2024 ·Journal of Pain and Symptom Management ·(unknown), (unknown), (unknown), Kristen DeSanto, Cara L. McDermott, Donald R. Sullivan, David B. Bekelman, Dio Kavalieratos	2
2	Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States 2024 ·Journal of Managed Care & Specialty Pharmacy ·Xiaodan Mai, Aaron B. Mendelsohn, James Marshall, Nancy D. Lin, Cara L. McDermott, (unknown), Pamala A. Pawloski, (unknown), Kimberly Daniels, Cheryl N. McMahill‐Walraven, Djeneba Audrey Djibo, (unknown)	1
3	Factors Associated With Hospital Admission in the Last Month: A Retrospective Single Center Analysis 2024 ·Journal of Pain and Symptom Management ·Jessica Ma, Maren K. Olsen, Cara L. McDermott, C. Barrett Bowling, Susan N. Hastings, (unknown), David Casarett	2
4	Real-world switching and discontinuation outcomes of infliximab biosimilars in patients with rheumatoid arthritis: A scoping review 2023 ·Journal of Managed Care & Specialty Pharmacy ·Yue Yin, Cara L. McDermott, (unknown)	2
5	Utilization, user characteristics, and adverse outcomes of insulin glargine originators and follow-on drug in patients with diabetes in the United States 2023 ·Journal of Managed Care & Specialty Pharmacy ·Ashish Rai, (unknown), Aaron B. Mendelsohn, James Marshall, Cara L. McDermott, Sengwee Toh, (unknown)	2
6	Effect of the COVID-19 Pandemic on Place of Death Among Medicaid and Commercially Insured Patients With Cancer in Washington State 2022 ·Journal of Clinical Oncology ·Laura Panattoni, Cara L. McDermott, (unknown), Qin Sun, Catherine R. Fedorenko, (unknown), Karma L. Kreizenbeck, Veena Shankaran, Scott D. Ramsey	5
7	What Does it Mean to be an Excellent Mentor? J. Randall “Randy” Curtis’ Living Legacy 2022 ·Journal of Pain and Symptom Management ·Cara L. McDermott, Heather Coats, Gwen M. Bernacki, Erin Abu‐Rish Blakeney, Crystal Brown, Nancy Lau, Robert Y. Lee, Matthew Modes, Angela Steineck, Jill M. Steiner, Mallory Taylor, Erin K. Kross	0
8	Cost data in implementation science: categories and approaches to costing 2022 ·Implementation Science ·Heather T. Gold, Cara L. McDermott, Ties Hoomans, Todd H. Wagner	59
9	Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product 2021 ·Drugs - Real World Outcomes ·Aaron B. Mendelsohn, James Marshall, Cara L. McDermott, Pamala A. Pawloski, Jeffrey S. Brown, (unknown)	2
10	Methodological Challenges for Epidemiologic Studies of Deprescribing at the End of Life 2021 ·Current Epidemiology Reports ·Jennifer Tjia, Jennifer L. Lund, Deborah S. Mack, (unknown), Yiyang Yuan, (unknown), (unknown), Cara L. McDermott	7
11	The Association between Chronic Conditions, End-of-Life Health Care Use, and Documentation of Advance Care Planning among Patients with Cancer 2020 ·Journal of Palliative Medicine ·Cara L. McDermott, Ruth A. Engelberg, James Sibley, Mohamed L. Sorror, J. Randall Curtis	19
12	Pharmacologic Management of Agitation in Patients with Dementia 2019 ·Current Geriatrics Reports ·Cara L. McDermott, David A. Gruenewald	24
13	Pragmatic methods to avoid intensive care unit admission when it does not align with patient and family goals 2019 ·The Lancet Respiratory Medicine ·Nita Khandelwal, Ann C. Long, Robert Y. Lee, Cara L. McDermott, Ruth A. Engelberg, J. Randall Curtis	17
14	Novel Data Linkages to Characterize Palliative and End-Of-Life Care: Challenges and Considerations 2019 ·Journal of Pain and Symptom Management ·Cara L. McDermott, Ruth A. Engelberg, (unknown), Li Li, Catherine R. Fedorenko, Scott D. Ramsey, J. Randall Curtis	11
15	Nonrelapse Mortality and Mycophenolic Acid Exposure in Nonmyeloablative Hematopoietic Cell Transplantation 2013 ·Biology of Blood and Marrow Transplantation ·Cara L. McDermott, Brenda M. Sandmaier, Barry E. Storer, Hong Li, Donald E. Mager, Michael Boeckh, Meagan J. Bemer, (unknown), Jeannine S. McCune	23
16	Complementary and Alternative Medicine Use, Patient-reported Outcomes, and Treatment Satisfaction Among Men With Localized Prostate Cancer 2012 ·Urology ·Scott D. Ramsey, Steven B. Zeliadt, David K. Blough, Catherine R. Fedorenko, (unknown), Cara L. McDermott, David F. Penson, Stephen K. Van Den Eeden, Ann S. Hamilton, Neeraj Arora	8
17	A Pilot Study of Website Information Regarding Aromatase Inhibitors: Dietary Supplement Interactions 2011 ·The Journal of Alternative and Complementary Medicine ·Cara L. McDermott, (unknown), Erin Sweet, Kimberly M Tippens, Jeannine S. McCune	7
18	Health Care Use and Primary Prophylaxis with Colony-Stimulating Factors 2011 ·Value in Health ·Sean D. Sullivan, Scott D. Ramsey, David K. Blough, Cara L. McDermott, Lauren Clarke, Jeannine S. McCune	7
19	Will Knowledge of Gene-Based Colorectal Cancer Disease Risk Influence Quality of Life and Screening Behavior? 2009 ·Public Health Genomics ·Scott D. Ramsey, David K. Blough, Cara L. McDermott, Lauren Clarke, Robin L. Bennett, Wylie Burke, Polly A. Newcomb	17
20	Sensitivity of Administrative Claims to Identify Incident Cases of Lung Cancer: A Comparison of 3 Health Plans 2009 ·Journal of Managed Care Pharmacy ·Scott D. Ramsey, John F. Scoggins, David K. Blough, Cara L. McDermott, Carolina Reyes	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact